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Imaging techniquesThe kidney is a very important complicated filtering organ of the body. When the kidney reaches stage 5
chronic kidney disease, end stage renal failure, the preeminent therapy is renal transplantation. Although
it is the best form of treatment, lack of kidney donors is still challenging. Therefore, all efforts should be
employed to prolong the survival rate of the transplanted kidney. However, graft dysfunction (e.g., acute
rejection) is one of the serious barriers to long term kidney transplant survival. Currently, graft dysfunc-
tion’s gold standard of diagnosis is renal biopsy. Although renal biopsy is helpful, it is not preferred due to
its invasive nature, high morbidity rates, and expensiveness. Therefore, noninvasive imaging techniques
have become the subject of extensive research and interest, giving a strong promise to replace, or at least
to decrease, biopsy usage in diagnosing graft dysfunction. This survey will discuss not only the current
diagnosis and treatment of graft dysfunction but also the state-of-the-art imaging techniques in detecting
acute renal transplant rejection.
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GFR glomerular filtration rate
MRI magnetic resonance imaging
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VI viral infection
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AT arrival time
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DTTP delta time to peak
DCE dynamic contrast-enhanced
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MI mutual information
AR acute rejection
MTT mean transit time
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R2⁄ relaxation rate
CR2⁄ mean cortical
MR2⁄ mean medullary
MCR2⁄ mean medullary cortical
TMR T-cell-mediated rejection
AMR antibody-mediated rejection
SNR signal-to-noise ratio
DW diffusion-weighted
ADC apparent diffusion coefficient
b-value gradient field strengths and duration
CrCl creatinine clearance
IGF initial graft function
TD true diffusion
ACR acute cellular rejection
CDFs cumulative distribution functions
SNCAE stacked non-negativity constrained autoencoder
USPIO ultrasmall superparamagnetic particles of iron oxide1. Introduction
The kidney is a very important organ. It is the main filtration
organ in the human body, keeping the nutrients that the body
needs in and expelling the waste that can become toxic. Maintain-
ing the health of this organ is very important. There are diseases
that can cause the kidney to decrease in function such as diabetes,
hypertension, glomerular disease, and polycystic kidney disease
[1]. These can result in a gradual loss of kidney function leading
to waste build up in the body and cause the patient to develop
chronic kidney disease (CKD).
Chronic kidney disease (CKD) affects about 26 million people
with 17,000 transplants being performed each year in the U.S.
[2,3]. Though this has greatly improved the outcome of patients
diagnosed with stage 5 CKD, complications can still arise. One
of the main concerns is graft dysfunction. Routine post-
transplantation clinical evaluation of kidney function is of
immense importance to prevent the graft loss. The diagnostic tech-
nique currently recommended by the National Kidney Foundation
(NKF) to measure overall kidney function is glomerular filtrationlease cite this article in press as: Hollis E et al. Towards non-invasive diagn
eview. Egypt J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.201rate (GFR), which is based on measuring the serum creatinine level.
However, this test has low sensitivity and is a late marker for renal
graft dysfunction (a significant change in serum creatinine level is
detectable only after the loss of 60% of renal function) [4]. The cur-
rent gold standard for diagnosing different types of kidney dys-
function is needle biopsy [4]. However, this can be difficult,
costly, and time-consuming. Renal biopsy can also result in compli-
cations such as infections, bleeding, and, at times, death. With the
evolution of computer aided diagnostic systems, we hope to diag-
nose different types of graft dysfunction, saving time and money.
Thus, the need for new noninvasive techniques that has the capa-
bility to provide accurate diagnosis of kidney dysfunction is of
countless clinical significance.
The main purpose of this paper is to present an overview of cur-
rent clinical techniques for renal transplant function evaluation as
well as an examination of new ways to improve the detection of
graft dysfunction using image-based technology.
The rest of this paper is organized as follows. Section 2 provides
a brief overview of the treatment options for people who develop
stage 5 CKD, concentrating on transplantation as a definitiveostic techniques for early detection of acute renal transplant rejection: A
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care, which includes possible complications that could arise with
a concentration on graft dysfunction. Section 4 will concentrate
on tests that are performed to detect graft dysfunctions including
the traditional methods such as blood, urine, and renal biopsy. This
is followed by the image based techniques such as magnetic reso-
nance imaging (MRI), and ultrasound.
2. Treatment
Luckily, there have been developments in treatments for
patients with stage 5 renal failure. Those treatments include blood
dialysis or renal transplant. Blood dialysis is when one’s blood is
filtered of waste or excess water, either with use of a machine out-
side the body (hemodialysis) or chemically inside the body (peri-
toneal dialysis) [5]. Though dialysis is a helpful treatment, a
longer term treatment would be kidney transplantation. This is
where a donor’s kidney is surgically inserted into the CKD patient.
That new kidney should improve filtration for the patient. Since
transplantation is the definitive therapy for End-Stage Renal Dis-
ease (ESRD), the following describes in more details the kidney
transplantation procedure and associated complications and
diseases.
2.1. Transplantation
As previously stated, renal transplantation is a surgical proce-
dure where a donated kidney is placed inside the patient with
CKD. However, it does not mean that a nephrectomy (i.e. removal
of the malfunctioned kidney) is performed on the patient with
CKD. The patient with CKD usually gets to keep both of the kidneys,
unless those kidneys are causing pain or other complications [6].
This means that the patient will have three kidneys after the pro-
cedure. The donated kidney also has its own ureter, renal artery,
and vein intact. The donated kidney is placed below (distal of)
the native kidneys with the donated ureter connecting to the blad-
der, and the renal artery and vein connecting to the iliac artery and
vein of the patient, respectively [7]. Fig. 1 demonstrates the entire
anatomy of a patient’s renal system after transplantation.
This procedure seems fairly simple in concept. However, the
process to find that donor can be fairly complicated not only med-
ically and logistically but also due to legal hurdles. There are two
different types of donors that can be used for CKD; cadaver and liv-
ing donors. Only one third of the transplantations are from living
donors while two thirds of the transplantations are from cadaver
donors [8]. The type of donor is often the first decision that the
physician and the CKD patient must make. Often a more desirable
choice would be to have a living donor give one of their kidneys.Fig. 1. Anatomy of renal system of a
Please cite this article in press as: Hollis E et al. Towards non-invasive diagn
review. Egypt J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.201However, this is not without its complications. The donor must
meet all criteria such as being HLA (+ or ) and/or ABO compatible,
physically in good health, and in no way coerced against their will
to donate [8,9]. This means that the donors can back out at any
time. This is why even if there is a willing living donor the physi-
cian may persuade the patient to get on the United Network of
Organ Sharing (UNOS) [10]. Depending on where the patient is
on the list determines if and when they will receive a donor. The
donated kidneys from this list are from cadaver donors. In order
for the cadaver’s kidney to be viable the kidney must be function-
ing before death and the manner of death must not damage the
organ. Also the time and location of death may play a part since
the kidney must not decompose before the kidney can be donated
[8]. In the U.S., the living donors must be willing to give up their
kidney; cadaver donors must also make it clear that they are will-
ing to be a donor after death.
With all of these criteria, it is no wonder that although there are
about 17,000 kidney transplants performed annually in the United
States, there are still about 100,800 people waiting for a kidney.
With this in mind, it is very important that the transplanted kidney
is kept viable as long as possible so that a nephrectomy and repeat
transplantation do not have to be performed [3]. In the following
section, we shall overview what happens during post-
transplantation care, which should improve the viability of the
organ post-transplantation. This includes follow up procedures
and the complications that arise for transplant patients.3. Post-transplant follow-ups and complications
Just as with any medical procedure, complications can arise,
such as infection and bleeding so one must remain under the con-
stant care of one’s physician. They must continue follow ups to
insure that the new kidney is functioning and that new complica-
tions do not arise. To prevent new complications from arising, the
patient should follow the instructions of their physician by taking
their anti-rejection medications and visiting their physician as
directed [11]. The frequency at which a patient has to visit their
physician will decrease as time after transplantation increases.
Once the patient has reached 210 days post-operatively, they
should be seeing their physician monthly or if abnormalities arise
[12]. During those clinical visits various tests such as examining
the patient’s weight, blood pressure, and temperature will be done
to assess both the overall health of the patient and the health of the
kidney. The urine and blood lab test will be discussed later in this
article. If these tests appear abnormal, the physician may order a
renal biopsy and/or scans [13]; both will be discussed in greater
detail later on in the article. For now, this article will concentrate
on the complications that can arise during these tests, specificallypatient after kidney transplant.
ostic techniques for early detection of acute renal transplant rejection: A
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section will take a look at those types and concentrate specifically
on graft dysfunction. First, this article will explain different types
of complications other than graft dysfunction.
3.1. Types of complications
There are six categories of complications including: urological
complications, vascular complications, fluid collection, recurrent
native renal disease, graft dysfunction, and neoplasms. This section
will take a short look at the first five complications, then the next
section will go a little more in depth for graft dysfunctions. Urolog-
ical complications are simply when organs involved in the urinary
system such as the bladder, urethra and ureter have urine that is
leaking and/or being obstructed [14,15]. Vascular complications
are complications that are associated with the vascular system of
the renal system, i.e. renal or iliac artery/vein. Vascular complica-
tions can include narrowing, blockage or formations of holes in
the vascular system [16]. Fluid collection is closely related to uro-
logical complications and/or vascular complication in that if there
are urological or vascular complications, fluid such as blood or
urine will collect in areas where they are not supposed to be col-
lecting. This will create urinomas hematomas, abscesses, or lym-
phoceles [15–17]. Neoplasms are abnormal growth such as
tumors that grow on the renal system and other areas. This is said
to be caused by the prolonged exposure to immune suppressing
drugs [16,18,19]. Lastly, recurrent native renal disease is when
the disease that caused the patient to develop CKD in the first
place, such as diabetes, is now affecting the donated kidney
[20,21]. It is possible for the patient to develop a combination of
these complications. It is important that for any of these complica-
tions, diagnosis and treatment are done as soon as possible. Most
of these complications are usually easier to detect as compared
to graft dysfunction. This is because these complications can be
detected using various imaging techniques such as ultrasounds
and MRIs [22]. These imaging techniques will be discussed later
on in the paper, but the concentration will be more on graft dys-
function. The complication and cause that is more challenging to
diagnose is graft dysfunction, which shall be examined next.
3.2. Graft dysfunction
Graft dysfunction simply means that the newly transplanted
organ is no longer functioning. Toxins then build up, and the body
rejects the transplanted organ [16]. It was calculated that within
the first 5 years post transplantation, 15% of patients will experi-
ence graft dysfunction [23]. There are three classes of graft dys-
function: hyperacute, acute, and chronic. The type of graft
dysfunction is differentiated by the mechanism and somewhat
by the time of dysfunction onset [24]. Hyperacute rejection is rel-
atively rare nowadays. This class of rejection is caused by antibod-
ies attacking the donated organ due to the donated organ having
the wrong HLA (+ or ) and/or ABO blood antigen and will present
itself within in minutes or hours after transplantation [9]. There is
no cure for hyperacute rejection [25]. Chronic kidney rejection’s
mechanism is not well understood but appears to present itself
after 5 years post-transplant [9]. This article will concentrate on
acute kidney rejection (AKR). Just as there are different types of
complications in renal transplant, there are different causes of graft
dysfunction. This can provide somewhat of a challenge in diagnosis
and treatment. This is due to the fact that there is a different treat-
ment for each cause of graft dysfunction. There are four different
causes of graft dysfunction; they include: acute tubular necrosis
antibody-mediated rejection (ATN), T-cell mediated rejection,
immunosuppressive toxicity (IT), and viral infection (VI). ATN is
when the antibodies of the patient recognize the newly donatedPlease cite this article in press as: Hollis E et al. Towards non-invasive diagn
review. Egypt J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.201kidney as a foreign body causing the tissue to become necrotic
and die. It is treated with a drug therapy regimen that may include
plasmapheresis, mycophenolate mofetil, and tacrolimus [26–28].
T-cell mediated rejection is when killer T-cells attack the donated
organ causing apoptosis in the tissue [29]. The treatment for T-cell
mediated rejection includes drugs such as corticosteroids, antithy-
mocyte globulin, and immunosuppression therapy. If the patient
has antibody-mediated rejection they may not respond to the T-
cell mediated rejection treatment [30–32]. Immunosuppressive
toxicity is when the immunosuppressive drugs that are supposed
to be preventing the immune system from rejecting the donated
kidney actually cause renal failure since these drugs can be
nephrotoxic. Treatment for this would be to cease or change the
medication, or to reduce the dose of the nephrotoxic drug such
as cyclosporine and tacrolimus [33–35]. VI is when viruses such
as Cytomegalovirus or Herpes simplex virus enter the body and
damage the kidney [36]. Treatments for VI may include adminis-
tering immunosuppressant and/or antiviral medications [26]. The
causes of AKR can be presented singularly or in combination,
which can add to the difficulty in diagnosing the cause of AKR.
How the cause of these graft dysfunctions are diagnosed will be
discussed in the next section of this article.4. Detection/assessment of renal rejection
It is important that the patient keeps regular visits with their
physician in order to ensure that their newly transplanted organ
is in working order. The post-transplantation follow-up’s main
concern is to keep the graft viable for as long as possible. If the
patient continues regular follow-ups and notifies the physician of
any symptoms that arise, it is possible that they can catch the
problem early and save the donated organ. This paper will give
an overview of the existing techniques/methods for diagnosing
graft dysfunction. This includes both traditional non-imaging clin-
ical methods and the imaged-based techniques that are in use but
are still being developed and/or improved for use. More details
about both methods are given below.4.1. Traditional methods
Traditionally, during a routine follow-up a blood and urine anal-
ysis will be implemented. If there are any abnormal results in
either of these, the physician may order a renal biopsy to get a
definitive diagnosis. This diagnosis should also tell the physician
what is causing the kidney malfunction. This next section will
show how these diagnoses are determined. First, this article will
discuss urine testing.4.1.1. Urine tests
This method is very simple in use. It can test for multiple sub-
stances and is non-invasive. Using the patient’s urine, the physi-
cian is able to measure a number of biomarkers to determine
Glomar Filtration Rate (GFR). Most often the biomarker used to cal-
culate GFR is serum creatinine. To calculate GFR, the concentration
of creatinine found in the urine sample is placed into an equation
which has constants that change based on sex, race, and age. Using
the calculated GFR, one is able to determine what stage of function
the kidney(s) are in, 0 being at an increased risk and 5 being end
stage renal failure [37,38]. This diagnostic technique is presently
suggested by the National Kidney Foundation (NKF) to measure
overall kidney function. However, this test has low sensitivity
and is a late stage marker of renal dysfunction (a significant change
in serum creatinine level is detectable only after the loss of 60% of
renal function), and it does not assess the function of individualostic techniques for early detection of acute renal transplant rejection: A
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test.
4.1.2. Blood test/works
This method is similar to urine analysis in that it measures esti-
mated GFR using serum creatinine. However, since it does pierce
the skin when obtaining the blood, this test is slightly more inva-
sive. A complete blood count and differential count (CBC and diff)
[39] measures more substances than urine including detecting the
presence of burred blood cells which can be present in patients
with CKD. Burr cells are blood cells that appear almost gear like.
They appear when there is an excess amount of waste in the body,
which is likely to happen in patients with CKD [40,41]. Though
blood analysis has slightly more benefits than a urine test, it has
the similar setback in that the test has low sensitivity and is a late
marker of renal dysfunction and it does not assess the function of
individual kidneys [4]. The last traditional method that shall be
discussed is a renal biopsy.
4.1.3. Biopsy (‘‘Gold Standard”)
Renal biopsy is a traditional method for the graft function
assessment that is by far the most invasive, but to date is consid-
ered the gold standard. This procedure is performed using a renal
biopsy needle that is inserted into the patient’s back and kidney
while being guided by a camera, ultrasound, or X-ray, as shown
in Fig. 2 [39]. The tissue that is obtained is read using a microscope
[42]. The patient is fully conscious and told not to move [39]; if one
should move, they run the risk of piercing other organs. Along with
the risk of piercing other organs the patient also runs the risk of
excessive bleeding and infections. Excessive bleeding can present
itself more so in a patient who is on blood thinners. Infections
are likely to occur since the patient is more than likely on an
immunosuppressive therapy regimen [23,43]. These complications
can lead to nephrectomy or even death; both occur in 1 in every
1000 renal biopsies [23].
Along with the invasiveness of the procedure, there are multiple
setbacks that are associated with this procedure. Renal biopsies,
although a useful tool, have the tendency to give a missed diagno-
sis or inaccurate estimate of the extent of the problem. This is
because it is only sampling a small portion of the kidney and if
off target in the slightest can miss an effective portion of the kidney
and give a false negative. This would mean that a repeat biopsy
may have to be performed causing the patient more pain andFig. 2. Example of renal biopsy proc
Please cite this article in press as: Hollis E et al. Towards non-invasive diagn
review. Egypt J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.201precious time lost in order to save the graft. On the subject of time,
the time it takes to obtain the results can take up to two weeks
[44]. That time which could be used for treatment is wasted and
can result in failure of the donated kidney. On top of these set-
backs, the financial cost of the procedure can reach over $20,000
[45]. So this test cannot only cause physical pain but also create
more of a financial burden.
Though these tests have been routinely used for transplant
assessment and have helped in improving graft survival, one can
see that there needs to be a better way to diagnose and differenti-
ate the cause of graft dysfunction. Additionally, existing tech-
niques, i.e. GFR and biopsy, for diagnosis of renal rejection are
late biomarkers. Moreover, renal biopsy has significant morbidity,
is very expensive, takes up to two weeks to get the final report, and
can result in over- or under-estimates of problems by only sam-
pling small areas of the kidney. Therefore, the development of
non-invasive tests to monitor kidney transplant rejection status
is of immense importance. This, in turn, will allow doctors to inter-
vene early to prevent rejection and the damage it causes, which
will improve long-term outcomes.
The following section will overview existing non-invasive imag-
ing techniques and their possible use for assessing renal function
and diagnosing graft dysfunction. The imaging techniques that
are included in this article are ultrasound and MRI.5. Image-based techniques for renal transplant evaluation
The progress of computer-aided diagnosis (CAD) systems for
renal transplant assessment using diverse imaging modalities is a
current area of amplified research. Non-invasive imaging-based
techniques have been clinically used to assess transplanted kid-
neys with the advantage of providing information on each kidney
separately. For example, radionuclide imaging (also termed
scintigraphy), the traditional technique in renal imaging, is an
admirable modality for gauging graft function, both qualitatively
and quantitatively, while also assessing for common complications
[46]. However, this procedure appears to miss the mark in present-
ing accurate anatomical information due to its narrow spatial res-
olution. Therefore, functional idiosyncrasies inside different areas
of the kidney (such as cortex and medulla) cannot be differentiated
precisely [47]. Additionally, radionuclide imaging contains radia-
tion exposure [48], thus restraining the range of its applications,
particularly in monitoring diseases such as ATN or cyclosporineedure guided with ultrasound.
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ment that uses contrast agents that permits accurate evaluation of
numerous diseases and complications in renal transplantation and
at a lower cost than magnetic resonance imaging (MRI) [50]. Con-
versely, data gathered by CT to sense renal acute rejection lacks
specificity and the contrast agents used are currently nephrotoxic.
Therefore, at present CT has a restricted role in detecting acute
renal rejection [51]. In contrast to these radionuclides and CTs,
ultrasound (US) and magnetic resonance imaging (MRI) are the
most popular imaging modalities used for the diagnosis of kidney
diseases. In the following sections, this survey will outline different
CAD systems for diagnosing acute renal rejection using these imag-
ing modalities.
5.1. Ultrasound (US) imaging
Ultrasound (US) imaging is usually used for the early assess-
ment of renal allografts functionality in the postoperative period
as well as for the assessment in the long-term follow-up due to
being a relatively easy to be performed and repeated, inexpensive,
and non-nephrotoxic imaging modality [52]. Pulsatility index (PI)
and resistance index (RI) are the most common measurements to
assess renal functionality using US. Below, we will discuss some
recent studies that assessed renal transplants using different forms
of ultrasound (e.g., power Doppler (PD), color Doppler (CD), con-
trast enhanced (CE), etc.) as shown in Fig. 3.
In an investigation to illustrate the factors that impact PI and RI
in patients with immediate (IGF), slow (SGF), or delayed (DGF) kid-
ney graft function, Chudek et al. [53] observed that ischemic injury,
which occurred chiefly prior to organ harvesting, played an over-
riding role in defining intra-renal resistance in the early post-
transplant period. A study by Saracino et al. [54] investigated
whether the long-term renal functionality could be predicted using
RI measurements obtained early after renal transplant. On the
other hand, Kramann et al. [55] concentrated in their study onFig. 3. Example of diff
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graft survival. They concluded that, for prediction of long-term
allograft survival, RI measurements should be obtained 12–
18 months post-transplantation. Krejvci et al. [56] utilized a CD
imaging, PD imaging, and composite gray-scale to examine the
power of US for early detection of a subclinical acute rejection. A
significant difference between the four different groups in their
study was obtained. In another study by Damasio et al. [57], the
ability of Doppler US to differentiate between dual and single kid-
ney transplantation (DKT and SKT, respectively) was exploited.
After the measurement of RI parameters for both DKT and SKT
groups, they concluded that those patients with DKT had lower
kidney volumes and higher RI than those with SKT.
A study by Shebel et al. [58] investigated the ability of PD in the
differentiation between ATN and acute rejection (AR). Their study
included 67 renal transplant recipients in the early post-
transplantation period. After a manual placement of ROIs, cortical
perfusion (CP) and RI were measured for all recipients and CP
was tested with respect to RI and serum creatinine (SCr). Upon
their own CP grading scale system, they found a statistical signifi-
cant correlation between their SCr and CP grading (P < 0.01) and
between RI and CP grading (P < 0.05). They concluded that the
PD using CP grading is more sensitive in the detection of early
AR compared to RI and cross-sectional measurements.
Fischer et al. [59] proved the dominance of ultrasound contrast
media (USCM) to orthodox US that uses the RI indicator in the
diagnosis of early stage allograft dysfunction. Additionally, Benozzi
et al. [60] discovered that both CEUS and US could identify grafts
with early stage dysfunction, but only some CEUS derived param-
eters could discriminate between AR and ATN. Schwenger et al.
[61] exploited the power of CE sonography (CES) in early predic-
tion of long-term renal transplant functionality compared to CD
ultrasonography (CDUS). In their study, 68 renal transplants were
investigated using both CES and CDUS one week after transplanta-
tion. Renal blood flow (RBF) and RI were measured for allerent ultrasounds.
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ical data represented by glomerular filtration rate (GFR) in a post-
transplantation period from one week to one year. They concluded
from their observations that RBF measurement using CES was sig-
nificantly correlated with kidney functionality in the aforemen-
tioned period after transplantation, in contrast with RI
measurement using CDUS. Another study was explored by Gocze
et al. [62] to differentiate between acute kidney injury (AKI) stages
using CEUS based on the quantification of blood perfusion. Instead
of generating time-intensity curves (TIC), they used another quan-
tification method called arrival time parametric imaging (ATPI).
Their study included 10 patients who underwent CEUS of which
4 patients had no evidence of AKI, 1 with stage 1 AKI, and 5 with
stage 2 or 3 AKI. Color-maps based on inflow time (IT) of the con-
trast agent were generated using the CEUS-ATPI quantification
method and were divided into six major categories based on their
values. Then, these ITs were assessed for different poles of kidney
cortex (i.e. lower, middle, and upper) and the total IT was the
sum of all arrival times of these three poles for each kidney. They
observed that patients with stage 2 or 3 AKI have more delayed
ITs than those of the other groups. They concluded that CEUS-
ATPI technique may help in detecting different stages of AKI.
Recently, Jin et al. [63] assessed renal allografts using CEUS. In their
study, 57 renal transplant patients underwent CEUS. Then, they
were divided into three groups: 23 patients with AR (group 1),
10 patients with ATN (group 2), and 24 patients with normal allo-
grafts (group 3). After a manual placement of ROIs, a new index to
detect AR called rising time (RT) was measured instead of arrival
time (AT). In addition, time to peak (TTP) and delta time among
ROIs (DRT and DTTP) were measured, analyzed, and correlated
with clinical data (e.g., GFR). They found that RT, TIP, and (DRT
and DTTP) were significantly higher in group 1 compared to those
in group 2 and group 3.
Although several studies utilized US to evaluate and assess
renal functionality pre- and post-transplantation by evaluating
conventional ultrasound parameters, for instance the PI and RI,
two contradictory studies [64,65] concluded that RI is not an exact
sign of renal graft dysfunction, and it could only offer a predictive
marker of the graft. Moreover, Doppler US may give high RI and PI
values (>0.8), which is an indication comparable to those of ATN
[55,66]. These contradictions led researchers and investigators to
examine a different imaging modality to assess renal functionality
(e.g., MRI). In the next section, we will discuss up-to-date studies
utilizing different MR imaging modalities.5.2. Magnetic resonance imaging (MRI)
MR imaging is a non-ionizing technique that has become the
most important non-invasive diagnostic tool in many clinical
applications [67]. MRI not only provides excellent morphological
information but also possesses the ability to offer the best soft tis-
sue contrast compared to all imaging techniques (e.g., US and CT),
which allows advanced analysis of different aspects of renal func-
tion. There are various specific types of MRI scans. While some ofFig. 4. Example of a DCE-MRI sequence
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other MRI modalities, such as dynamic MRI, BOLD MRI and diffu-
sion MRI are frequently used for renal function evaluation. Next,
we overview the recent studies utilizing these MRI modalities for
renal transplant assessment.5.2.1. Dynamic contrast-enhanced (DCE) MRI
Renal dynamic MRI is an emerging imaging technique for
assessing kidney function. The technique is based on repeated
imaging of the organ-of-interest before and after administration
of a contrast-gent. Fig. 4 shows a typical example of DCE-MRI of
the kidney. In recent years several studies have exploited DCE-
MRI to non-invasively analyze kidney function in both native and
transplanted kidneys. This imaging modality has the ability to
non-invasively characterize important functional parameters
(e.g., RBF, GFR, and renal plasma flow (RPF)) as well as tissue-
specific functional changes.
In particular, a study by de Priester et al. [68] utilized dynamic
MR enhancement curves to qualitatively evaluate diseased (27
patients) and nondiseased (8 patients) renal transplants. Cortical
and the medullary enhancement parameters were obtained from
a physiological model that was fitted to the raw data. Cortical arte-
rial blood volume and medullary wash-out rates were found as the
main discriminatory parameters between diseased and nondis-
eased patients. Yuksel [69] introduced a DCE-MRI-based CAD sys-
tem for the evaluation of transplant function, which employed
deformable image segmentation, kidney registration, and cortical
perfusion construction. After kidney segmentation, a manual corti-
cal ROI is used to construct the perfusion curve from the co-aligned
images and the kidney function is evaluated visually based on the
pattern of the constructed curves. Several studies [70–73] have
been developed for early diagnosis of acute transplant rejection
and included automated kidney segmentation, local kidney align-
ment, and classification of the allograft status. Empirical (nonpara-
metric) cortical parameters were employed for the evaluation of
kidney status using: the peak signal intensity, the time-to-peak,
the wash-in slope (slope between the peak and the first minimum),
and the wash-out slope (peak and the signal measured from the
last image in the sequence). A supervised Bayesian classifier was
employed and the system classified 13 out 15 and 15 out of 15 cor-
rectly for both training and testing, respectively. Similar
approaches were proposed in [74–76]. The studies utilized a global
alignment step of the MR images, the whole kidney perfusion
curves were analyzed rather than the cortical one as in [70–73],
and the systems were evaluated on a 100 patient cohort and
achieved a 94% diagnostic accuracy using Bayesian supervised clas-
sifier. Functional evaluation of cortical and medullary regions by
Rusinek et al. [77] exploited rigid alignment, graph-cut segmenta-
tion, and compartmental modeling. Their framework was tested on
22 clinical data sets and the study concluded that the accuracy and
precision in RPF and GFR are acceptable for clinical use.
A semi-automated framework was proposed by Zikic et al. [78]
to evaluate kidney kinetic parameters. Their framework employed
manually segmenting the kidney and applying motion correctionwith pre-, post-, and late-contrast.
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image motion. Functional parameters (plasma volume and tubular
flow) evaluation, however; was performed visually by trained
physicians for 10 data sets of healthy volunteers. De Senneville
[79] conducted a similar study to evaluate renal function for
healthy volunteers and transplant patients. Their framework per-
forms sequentially rigid-body registration, manual cortex segmen-
tation, and the GFR estimation using Patlak-Rutland model.
Compared to the transplanted kidneys, a significant uncertainty
reduction on the computed GFR for native kidneys was observed.
Aslan et al. [80] developed an automated CAD system to classify
normal kidney function from kidney rejection using DCE-MRI. Fol-
lowing kidney segmentation, three classification methods (least
square support vector machines (LS-SVM), Mahalanobis distance,
and the Euclidean distance) were compared to assess transplant
status based on medullary perfusion curves. On a cohort of 55 clin-
ical data sets, they achieved a diagnostic accuracy, sensitivity, and
specificity of 84%, 75%, and 96%, respectively using the Maha-
lanobis distance-based classifier. A trace kinetic modeling-based
framework was proposed by Anderlik et al. [81] for quantitative
assessment of kidney function. The GFR was estimated from the
time-intensity curves for 11 data sets after motion correction using
Sourbron et al. [82] compartment model. A framework by Zollner
et al. [83] employed a k-means clustering [84] method to extracted
regional functional kidney parameters. Only four dynamic MRI
data sets were used and qualitative evaluation of the mean signal
intensity time courses of kidney regions was performed. Wentland
et al. [85] utilized MRI-based intrarenal perfusion measurement to
differentiate between normal-functioning kidney allografts and
allografts with ATN or acute rejection (AR) on a cohort of 24 biopsy
proven patients. The study concluded that the cortical and medul-
lary blood flow is significantly reduced in grafts experiencing AR,
as compared with normal grafts. Additionally, AR patients demon-
strated medullary blood flow reduction as compared with ATN
patients.
Recently, a study by Abou El-Ghar et al. [86] explored the feasi-
bility of DCEMRI in evaluation of renal allograft dysfunction. Their
CAD system employed computer based techniques for motion cor-
rection and creation of renographic curves. Functional evaluation
on 55 patients using the mean medullary intensity achieved sensi-
tivity, specificity and accuracy of 75%, 96% and 84%, respectively, to
separate normal kidneys from impaired ones. Yamamoto et al. [87]
utilized dynamic MRI to prospectively assess its ability to identify
the cause of acute graft dysfunction. Their study employed 60
patients, 31 of which had normal function and 29 had acute dys-
function due to AR. Their study employed a multicompartmental
tracer kinetic model to estimate the GFR and mean transit time
(MTT) at different compartments of the kidney. The study docu-
mented differences in the fractional MTT values between normal
grafts and grafts undergoing AR or ATN; however, substantial over-
laps among these groups and with normal kidneys were observed.
Hodneland et al. [88] developed a framework for the estimation of
kidney indexes. Their approach combined viscous fluid model for
motion correction of the kidney and semi-automated kidney seg-
mentation with the nearest neighbor approach. Two healthy vol-
unteers were enrolled in the study with a total of four data sets
for evaluation. The study reported a slight underestimation of
GFR values compared with the creatinine reference values. A study
by Positano et al. [89] included a two-step rigid registration and
adaptive prediction of kidney position for the estimation for renal
parameters. Perfusion curves were constructed for both automati-
cally and manually registered data sets. Then, four functional
indices (peak signal intensity, MTT, initial up-slope, and time to
peak) were extracted. The study concluded that for both curves
the perfusion parameters were similar. A framework by Khalifa
et al. [90,91] was proposed for automated classification of kidneyPlease cite this article in press as: Hollis E et al. Towards non-invasive diagn
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the local kidney motion correction using by a Laplace partial differ-
ential equation-based method [92,93]. Their initial study [90]
included only 26 data sets, a K-nearest neighbor classifier, and
two empirical parameters (the time-to-peak and wash-out slope)
for evaluation. Their system achieved a 92.31% correct classifica-
tion using the whole kidney perfusion curves. Their framework
was extended in [91] by using four augmented cortical empirical
parameters (peak intensity value, time-to-peak, up-slope and aver-
age plateau) by the genetic algorithm [94]. Unlike [90], the system
was tested on 50 patients, and the overall diagnostic accuracy
increased to 96%. Another study [95] extended the work in
[90,91] and employed the gamma-variate analytical function-
based model to fit agent cortical kinetic curves. Both functional
model parameters and the time-to-peak and average plateau were
used to assess the transplant status in a cohort of 50 patients.
Although DCE-MRI has been employed as a widespread imaging
technique to develop several CAD systems for renal transplants
assessment purpose, the contrast agents may implicate nephro-
genic systemic fibrosis; thus, many medical centers are reluctant
in applying the DCE-MRI to patients with renal disease [88]. In
order to circumvent this major drawback, DW-MRI and BOLD-
MRI have been recently exploited to assess renal transplants as
they do not involve any use of contrast agents, like DCE-MRI.
Below, we will briefly discuss some recent renal transplant assess-
ment studies using BOLD-MRI. This is followed by a short discus-
sion on other studies that utilized DW-MRI to assess renal
transplants.
5.2.2. Blood oxygen level dependent (BOLD) MRI
In addition to DCE-MRI, another imaging technique, called
BOLD-MRI, has been utilized to study renal rejection using the
amount of oxygen diffused blood (i.e. oxygen bioavailability) in
the kidney determine if it is functioning properly. Specifically,
the amount of deoxyhemoglobin is measured by the apparent
relaxation rate (R2⁄) parameter [96], see Fig. 5.
In particular, Djamali et al. [97] investigated the ability of
BOLD-MRI to assess renal allografts. In their study, 23 patients
underwent BOLD-MRI scans, of which 5 were normal allografts
and 18 had acute allograft dysfunction (5 with ATN and 13 with
AR). Medullary and cortical ROIs were placed, and mean cortical
(CR2⁄), medullary (MR2⁄), and medullary to cortical (MCR2⁄) were
calculated. They found that MR2⁄ and MCR2⁄ values of patients
with ATN and AR were significantly decreased more than those
with normal allografts. However, no differences in CR2⁄ values
between the different groups were observed. In a similar study
by Han et al. [98], BOLD-MRI was conducted to differentiate
between patients with AR and ATN after transplantation. Their
study included 110 patients; 82 with normal allografts (group 1)
and 28 with kidney dysfunction, including 21 with AR (group 2)
and 7 with ATN (group 3). Group 2 was divided into two sub-
groups: 13 patients with T-cell-mediated rejection (TMR) and 8
patients with antibody-mediated rejection (AMR). Manual ROIs
were placed in the cortical and medullary regions, and CR2⁄,
MR2⁄, and MCR2⁄ were compared between different groups. They
performed a statistical analysis, and they found that values of
CR2⁄, MR2⁄, and MCR2⁄ of group 2 were reduced compared to
those of the other two groups. Contradictory to Djamali et al.
[97] study, they found that values of MR2⁄ of group 3 were higher
than those of group 1. However, no significant difference was
observed between the TMR and AMR subgroups.
Sadowski et al. [99] employed BOLD-MRI to assess kidney trans-
plants. Manual cortical and medullary ROIs were placed on 17
patients who underwent BOLD-MRI scans, and these patients were
divided into three groups: 5 patients with normal allografts (group
1), 4 with ATN (group 2), and 8 with AR (group 3). The MR2⁄ andostic techniques for early detection of acute renal transplant rejection: A
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Fig. 5. BOLD-MRI grey scale images (a) normal kidney and (b) kidney with graft dysfunction and R2⁄ color-maps images (c) normal kidney and (d) kidney with graft
dysfunction.
E. Hollis et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxx 9CR2⁄ were calculated in the same way as their previous study [97],
and compared between the different groups. Specifically, MR2⁄ val-
ues of group 3 allografts were decreased compared to those of
group 1 and group 2, while no significant difference was observed
in MR2⁄ values between group 1 and group 2. However, no differ-
ence was detected in CR2⁄ values among the three groups. Another
interesting study by Liu et al. [96] was investigated to detect renal
allograft rejection using BOLD-MRI. A total number of 50 patients
with renal allografts were included and divided into three groups
as 35 patients with normal allografts (group 1), 10 patients with
AR (group 2), and 5 patients with ATN (group 3). After cortical
and medullary ROIs placement, CR2⁄ and MR2⁄ were measured
to assess the three groups. Group 2 had the lowest MR2⁄, while
no significant difference was detected in CR2⁄ values among the
three groups.
Although BOLD-MRI is a valuable imaging technique that has
been investigated by some researchers in detecting renal allografts
dysfunction, BOLD-MRI remains challenging, not only because of
the low of signal-to-noise ratio (SNR) and the weakness of the elec-
tromagnetic fields [100], but also the limited applicability of renal
BOLD-MRI due to kidney motions and susceptibility induced by
bowel gas which may lead to impaired image quality [101].
5.2.3. Diffusion-weighted (DW) MRI
Recently, DW-MRI has become a subject of extensive research
as an emerging imaging modality for renal function assessment
thanks to DW-MRI’s ability to provide both anatomical and func-
tional information, while avoiding radiation exposures (like CT)
and contras agents’ administration (like DCE-MRI). For DW-MRI,
its functional parameter, called apparent diffusion coefficient
(ADC), is estimated from different gradient field strengths and
duration (b-values), as shown in Fig. 6, to describe the uniqueFig. 6. Example of a DW-MRI seq
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fore, several studies have utilized DW-MRI to assess renal function-
ality by measuring the ADC values, but the results have varied [96].
A study by Eisenberger et al. [102] was conducted to assess
renal allografts functionality. They started with a manual place-
ment of ROIs in the upper, middle, and lower poles of the cortex
and medulla on several slices to cover large regions of the allograft.
Then, they calculated the means and standard deviations of the
ADCs from all b-values, which combines both the perfusion free
ADC and microcirculation parameters, quantified with perfusion
fraction, Fp. A significant reduction in these parameters was
observed in the cortex and the medulla for the AR and ATN
patients, and the aforementioned parameters were correlated with
the creatinine clearance (CrCl) values. Similarly, a recent study by
Hueper et al. [103] included 64 patients with renal allografts, of
which 33 were patients with initial graft function (IGF) and 31
were patients with DGF. These patients underwent DW-MRI scans
at two b-values (0 and 600 s/mm2). After placement of manual
ROIs and estimation of renal diffusion parameters, including ADC
and Fp, they concluded that renal diffusion parameters were signif-
icantly reduced in patients with DGF and their values well corre-
lated with renal function and renal allograft fibrosis in biopsy
specimens. Xu et al. [104] investigated the power of DW-MRI to
diagnose AR renal allografts on 26 biopsy-proven rejection and
43 non-rejection patients. Higher ADC values were obtained from
the normal allografts than those from AR allografts. The ROC curve
was constructed and demonstrated the best sensitivity and speci-
ficity at the b-value of 800 s/mm2. The functionality of 21 renal
allografts was assessed by Palmucci et al. [105]. Patients were
divided into three groups by their CrCl values and their ADCs and
true diffusion (TD) were estimated with renal function indices.
Manual ROIs of the transplanted kidney for the three groups wereuence at different b-values.
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positive correlation between the CrCl and both the ADC and TD,
as well as no difference between the ADC and TD values for the
contiguous groups have been found. The subsequent extension
[106] of these evaluations to 35 patients revealed a slightly smaller
positive correlation than the previously reported one [105]. How-
ever, acute rejection responses after transplantation could not be
detected.
Vermathen et al. [107] investigated the determination of long-
term (3 years) stability and potential changes for renal allograft
recipients. Cortical and medullary ROIs were selected and the
ADC values were measured from all b-values. A significant correla-
tion between different ADC components was demonstrated in the
case of normal transplants. However, the Fp values were the high-
est, and the medullary Fp had the greatest changes in the case of
reduced transplants. Possible relations between the selected labo-
ratory results and diffusion parameters in the early period after
kidney transplantation were explored by Katarzyna et al. [108].
To overcome the DW-MRI T2-‘‘shine-through” [109], additional
exponential ADCs were measured. These measurements were con-
ducted in the kidney’s cortex and medulla over multiple user-
defined ROIs at the b-values of 600 and 1000 s/mm2. They obtained
the best-quality ADmeasurement in the renal cortex at the b-value
of 1000 s/mm2 because of the relative variability of results and
SNR. In addition, strong dependencies were observed between
the ADC and exponential ADC, measured in the renal cortex at
b1000 s/mm2, and the estimated GFR. Kaul et al. [110] investigated
renal dysfunction assessment using cortical and medullary ADC
maps. A significant decrease in ADC values of medullas compared
to those cortexes in normal donor kidneys and normal allografts
was reported. Both the medulla and cortex ADCs decreased or
increased significantly for a rejection or the recovery from the
rejection itself, respectively. Abou-El-Ghar et al. [111] assessed
renal functionality for 70 renal allograft patients. DW-MRI scans
at two b-values of 0 and 800 s/mm2 were performed for 49 patients
with normal renal allografts (group 1) and 21 patients with acute
graft impairment (group 2: 10 acute cellular rejection (ACR), 7
ATN, and 4 immunosuppressive toxicity (IT) rejection types). In a
single cross-section, a user-defined ROI was placed at the middle
of the kidney and a pixel-wise ADC was calculated. Results shown
that the ADC values of group 2 were significantly lower than those
of group 1, and no overlap was detected between the ADCs of
group 1 and the ATN patients of group 2. However, the minimal
overlap was observed between the ADCs of group 1 and the
patients with the ACR and IT of group 2.
Detection of early renal allograft dysfunction caused by AR and
ATN was exploited by Liu et al. [96] using DW-MRI. With manually
selected cortical and medullary ROIs, lower ADC values of the AR
group than those of the control groups were revealed, whereas
no difference in the ADC values between the AR and ATN groups
was detected. A similar earlier study was conducted by Thoeny
et al. [112]. A recent study to distinguish between rejection and
non-rejection renal transplants was made by Shehata et al. [113].
Their study included 36 renal transplants of which 6 were non-
rejection and 30 were rejection. After DW-MRI data motion correc-
tion using a 2D B-splines approach, they segmented the largest
coronal cross-section of the kidney using a fully automated level
sets segmentation approach. Then, they calculated the ADCs at dif-
ferent b-values from the segmented coronal cross-section for each
subject. By using a leave-one-subject-out scenario along with a K
Star classifier, they got an 87% total classification accuracy. In addi-
tion, they depicted color-maps from the calculated ADCs for the
visualization purpose at different b-values. In a more recent study,
Shehata et al. [114] determined renal rejection type after trans-
plantation using DW-MRI. In their study, 39 renal rejection
transplants of which 31 were TMR and 8 were ATN-AMR. Firstly,Please cite this article in press as: Hollis E et al. Towards non-invasive diagn
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followed by kidney segmentation using geometric deformable
models were performed. Then, they calculated 3D cumulative
distribution functions (CDFs) from ADCs for the entire segmented
kidney at different low and high b-values of (10, 20, 30, 40, 50,
100) and (200 and 300) s/mm2, respectively. To account for blood
perfusion and water diffusion of the kidney, they fused the CDFs
at low and high b-values together. Finally, a 98% classification
accuracy was obtained using a stacked non-negativity constrained
autoencoder (SNCAE) classifier along with a leave-one-subject-out
scenario.
5.2.4. MRI with specific contrast agent (ultrasmall superparamagnetic
particles of iron oxide ‘‘USPIO”)
Ultrasmall Superparamagnetic Particles of Iron Oxide (USPIO) is
a contrast agent used in MRI that may one day be another tool that
could be used to diagnose renal rejection [115–121]. USPIO is said
to be able to detect the amount of macrophage that is present in
the kidney and therefore tell whether or not the kidney is under
stress and becoming rejected [115–121]. The more macrophages
that are present to absorb the particles through endocytosis, the
weaker the USPIO signal will show on the MRI [115–
118,120,121]. This technique has not been used in human kidney
transplant studies and is still in its infancy and more studies should
be performed. The present studies, which were done on rat models
in vivo, show some promise in diagnosing preclinical renal rejec-
tion [115,116,118,120,121]. Though there is some promise, USPIO
at present lacks specificity, which means the signal could be weak-
ened by other conditions or substances that are found in the body
other than the presence of macrophage. Another reason why USPIO
lacks specificity is that it cannot determine why the macrophages
are present at this time [115–121]. Even with some of these down-
sides there are enough possible positive aspects of USPIO that more
research should be conducted. The next step for research of USPIO
could be larger animal studies whose kidneys are more closely
related to humans. Once USPIO is proven relatively safe and effec-
tive in large animal studies, human studies should be considered.
6. Conclusion
Though the treatment of chronic kidney disease has improved
greatly with the use of transplants, there are still challenges such
as graft dysfunction that provide a challenge in maintaining sur-
vival of the new organ. In the future, the use of image-based diag-
nosis will be improved and implemented in the diagnosis of both
pre- and post-transplantation. It is hoped that by having these
improved imaged based CAD systems that diagnosis of graft dys-
function will be less invasive, more accurate, time saving, and inex-
pensive compared to renal biopsies and other traditional methods
of diagnosis. By having all of these advantages it is expected that
graft survival will improve in cases of graft dysfunction.
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